(Q35067732)

6 August 2017

1 reference

title

The prevention of type 2 diabetes--lifestyle change or pharmacotherapy? A challenge for the 21st century (English)

1 reference

6 August 2017

0 references

1 reference

Simpson RW

1

1 reference

6 August 2017

Shaw JE

series ordinal

2

1 reference

6 August 2017

Zimmet PZ

series ordinal

3

1 reference

6 August 2017

1 March 2003

1 reference

Diabetes Research and Clinical Practice

6 August 2017

1 reference

6 August 2017

59

1 reference

6 August 2017

3

1 reference

6 August 2017

165-180

1 reference

Globalization, coca-colonization and the chronic disease epidemic: can the Doomsday scenario be averted?

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Diabetes epidemiology as a tool to trigger diabetes research and care

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

The prevalence of diabetes mellitus and impaired glucose tolerance among Hong Kong Chinese adults of working age.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Prevalence of type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in the Japanese general population: the Hisayama Study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Rising prevalence of NIDDM in an urban population in India

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Economic consequences of diabetes mellitus in the U.S. in 1997. American Diabetes Association

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

The pathogenesis and prevention of diabetes in adults. Genes, autoimmunity, and demography

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Genetics of non-insulin dependent diabetes mellitus in 1990.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Diabetes: The genetic connections

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Genetics of type 2 diabetes and insulin resistance: knowledge from human studies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

High prevalence of NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians. Mauritius Noncommunicable Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

The clinical implications of impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

A two-step model for development of non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Impaired glucose tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Screening for diabetes: does measurement of serum fructosamine help?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Glucose tolerance test and glycosylated haemoglobin measurement for diagnosis of diabetes mellitus--an assessment of the criteria of the WHO Expert Committee on Diabetes Mellitus 1980.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Incidence of NIDDM and the natural history of IGT in Pacific and Indian Ocean populations

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Primary prevention of non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Risk factors for type 2 (non-insulin-dependent) diabetes mellitus. Thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Weight gain as a risk factor for clinical diabetes mellitus in women

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Visceral obesity: a "civilization syndrome".

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

High-fat, low-carbohydrate diet and the etiology of non-insulin-dependent diabetes mellitus: the San Luis Valley Diabetes Study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Dietary fat predicts conversion from impaired glucose tolerance to NIDDM. The San Luis Valley Diabetes Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Diet and risk of Type II diabetes: the role of types of fat and carbohydrate

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Dietary fat intake and risk of type 2 diabetes in women

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Dietary fiber, glycemic load, and risk of NIDDM in men

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Carbohydrates, dietary fiber, and incident type 2 diabetes in older women

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Alcohol consumption and risk of type 2 diabetes mellitus among US male physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

An epidemiological perspective of the relationship between physical activity and NIDDM: from activity assessment to intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Obesity in Britain: gluttony or sloth?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes. A longitudinal interventional study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Impaired glucose tolerance and NIDDM: does a lifestyle intervention program have an effect?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Moderately intense physical activities and high levels of cardiorespiratory fitness reduce the risk of non-insulin-dependent diabetes mellitus in middle-aged men

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Lifestyle changes may reverse development of the insulin resistance syndrome. The Oslo Diet and Exercise Study: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Marked Improvement in Carbohydrate and Lipid Metabolism in Diabetic Australian Aborigines After Temporary Reversion to Traditional Lifestyle

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

The Fasting Hyperglycaemia Study: I. Subject identification and recruitment for a non-insulin-dependent diabetes prevention trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

The Fasting Hyperglycaemia Study: II. Randomized controlled trial of reinforced healthy-living advice in subjects with increased but not diabetic fasting plasma glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Effects of physical activity counseling in primary care: the Activity Counseling Trial: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Tolbutamide-induced improvement in carbohydrate tolerance of young people with mild diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

THE LONG-TERM EFFECT OF TOLBUTAMIDE ON GLUCOSE TOLERANCE IN ADULT, ASYMPTOMATIC, LATENT DIABETICS

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Preventive tolbutamide treatment and arterial disease in mild hyperglycaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Treatment of borderline diabetes: controlled trial using carbohydrate restriction and phenformin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Effect of oral hypoglycaemic drugs on glucose tolerance and insulin secretion in borderline diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Short-term treatment of glucose intolerance in middle-aged subjects by diet, exercise and sulfonylurea

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

The Fasting Hyperglycaemia Study: III. Randomized controlled trial of sulfonylurea therapy in subjects with increased but not diabetic fasting plasma glucose.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Ramipril and the development of diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Troglitazone lowers islet fat and restores beta cell function of Zucker diabetic fatty rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Effect of Troglitazone on B Cell Function, Insulin Sensitivity, and Glycemic Control in Subjects with Type 2 Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Treatment of insulin-resistant mice with the oral antidiabetic agent pioglitazone: evaluation of liver GLUT2 and phosphoenolpyruvate carboxykinase expression

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Insulin action enhancement normalizes brachial artery vasoactivity in patients with peripheral vascular disease and occult diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

1 reference

7 January 2021

Treatment with low dose metformin in patients with peripheral vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Impaired glucose tolerance is normalized by treatment with the thiazolidinedione troglitazone.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Type 2 diabetes mellitus in minority children and adolescents. An emerging problem

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Diet, lifestyle, and the risk of type 2 diabetes mellitus in women

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Community-based approaches for the primary prevention of non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900275-9

7 January 2021

10.1016/S0168-8227(02)00275-9

Identifiers

DOI

1 reference

release_72fe4orzszcmtl36aomfz5uh44

6 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/72fe4orzszcmtl36aomfz5uh44

24 November 2022

mapped directly with Wikidata item

1 reference